Posteraro B.; Pea F.; Masucci L.; Posteraro P.; Sanguinetti M., Actoxumab + bezlotoxumab combination: what promise for Clostridium difficile treatment?, «EXPERT OPINION ON BIOLOGICAL THERAPY», 2018, 18, pp. 469 - 476 [Scientific article]
Righi E.; Muser D.; Carnelutti A.; Pea F.; Sartor A.; Bassetti M., Candida endocarditis and the impact of antifungal treatment on the corrected QT interval: a case report, «DRUGS & THERAPY PERSPECTIVES», 2018, 34, pp. 402 - 403 [Scientific article]
Peghin M.; Maiani M.; Castaldo N.; Givone F.; Righi E.; Lechiancole A.; Sartor A.; Pea F.; Livi U.; Bassetti M., Ceftolozane/tazobactam for the treatment of MDR Pseudomonas aeruginosa left ventricular assist device infection as a bridge to heart transplant, «INFECTION», 2018, 46, pp. 263 - 265 [Comment or similar]
Cojutti P.G.; Candoni A.; Lazzarotto D.; Rabassi N.; Fanin R.; Hope W.; Pea F., Co-administration of proton pump inhibitors and/or of steroids may be a risk factor for low trough concentrations of posaconazole delayed-released tablets in adult patients with haematological malignancies, «BRITISH JOURNAL OF CLINICAL PHARMACOLOGY», 2018, 84, pp. 2544 - 2550 [Scientific article]
Cojutti P.G.; Merelli M.; De Stefanis P.; Fregonese C.; Lucchese F.; Bassetti M.; Pea F., Disposition of ceftobiprole during continuous venous-venous hemodiafiltration (CVVHDF) in a single critically ill patient, «EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY», 2018, 74, pp. 1671 - 1672 [Comment or similar]
Cojutti P.G.; Barbarino C.; De Monte A.; Hope W.; Pea F., Higher than standard meropenem and linezolid dosages needed for appropriate treatment of an intracerebral hemorrhage patient with augmented renal clearance, «EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY», 2018, 74, pp. 1091 - 1092 [Scientific article]
Pea, Federico, Intracellular Pharmacokinetics of Antibacterials and Their Clinical Implications, «CLINICAL PHARMACOKINETICS», 2018, 57, pp. 177 - 189 [Scientific article]
Cojutti P.; Sartor A.; Bassetti M.; Scarparo C.; Pea F., Is meropenem MIC increase against KPC-producing Klebsiella pneumoniae correlated with increased resistance rates against other antimicrobials with Gram-negative activity?, «JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE», 2018, 14, pp. 238 - 241 [Scientific article]
Pea F; Lewis RE, Overview of antifungal dosing in invasive candidiasis, «JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY», 2018, 73, pp. i33 - i43 [Scientific article]
Pea F., Pharmacokinetics and drug metabolism of antibiotics in the elderly, «EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY», 2018, 14, pp. 1087 - 1100 [Scientific article]
Cojutti P.; Pai M.P.; Pea F., Population Pharmacokinetics and Dosing Considerations for the Use of Linezolid in Overweight and Obese Adult Patients, «CLINICAL PHARMACOKINETICS», 2018, 57, pp. 989 - 1000 [Scientific article]
Cojutti P.G.; Lugano M.; Righi E.; Della Rocca G.; Bassetti M.; Hope W.; Pea F., Population pharmacokinetics of fluconazole in liver transplantation: implications for target attainment for infections with Candida albicans and non-albicans spp, «EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY», 2018, 74, pp. 1449 - 1459 [Scientific article]
Concia E, Viscoli C, Del Bono V, Giannella M, Bassetti M, De Rosa GF, Durante Mangoni E, Esposito S, Giusti M, Grossi P, Menichetti F, Pea F, Petrosillo N, Tumbarello M, Stefani S, Venditti M, Viale P, The current role of glycopeptides in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in not neutropenic adults: the viewpoint of a group of Italian experts, «JOURNAL OF CHEMOTHERAPY», 2018, 30, pp. 157 - 171 [Scientific article]
Tangden T.; Cojutti P.G.; Roberts J.A.; Pea F., Valganciclovir Pharmacokinetics in Patients Receiving Oral Prophylaxis Following Kidney Transplantation and Model-Based Predictions of Optimal Dosing Regimens, «CLINICAL PHARMACOKINETICS», 2018, 57, pp. 1399 - 1405 [Scientific article]
Pea F.; Cojutti P.G.; Baraldo M., A 10-Year Experience of Therapeutic Drug Monitoring (TDM) of Linezolid in a Hospital-wide Population of Patients Receiving Conventional Dosing: Is there Enough Evidence for Suggesting TDM in the Majority of Patients?, «BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY», 2017, 121, pp. 303 - 308 [Scientific article]
